Cape Verde vs Mozambique: Prevalence rate of hypertension in women aged 30-79
Cape Verde
41.7
in 2019
Mozambique
41.9
in 2019
Cape Verde rank
55th
Mozambique rank
52nd
Prevalence rate of hypertension in women aged 30-79 over time
- Cape Verde
- Mozambique
How they compare
Mozambique currently reports 41.9 against 41.7 in Cape Verde, a difference of 0.2.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Cape Verde ahead.
Cape Verde ranks 55th and Mozambique ranks 52nd of 195 countries.
Cape Verde has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cape Verde | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 42.01 | 38.62 | 3.39 | Cape Verde |
| 2000s | 44.24 | 41.36 | 2.88 | Cape Verde |
| 2010s | 43.17 | 42.54 | 0.63 | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Cape Verde or Mozambique?
- Mozambique, at 41.9 against 41.7 in Cape Verde as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Cape Verde and Mozambique?
- 0.2, with Mozambique ahead.
- How many years of comparable data are there for Cape Verde and Mozambique?
- 30 years are reported by both, from 1990 to 2019.
- How do Cape Verde and Mozambique rank globally for prevalence rate of hypertension in women aged 30-79?
- Cape Verde ranks 55th and Mozambique ranks 52nd of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.